The discussion between the panelists aim to give insight into:

-How should the industry incorporate vaccination status for covid, and any other virus, in the pricing and underwriting. How will it impact the scheme and the FCL

-How do claims teams deal with the volatility in claim numbers to ensure timely payment

-How should brokers respond to sharply increased pricing in setting benefit levels and selecting insurers

-Should we expect changes to traditional group risk products, or the discontinuance of certain products

-Do they expect that pricing will return to pre-pandemic levels

More topics will be discussed as they develop during the conversation.